Your browser doesn't support javascript.
loading
Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey.
Kim, Ah-Ra; Minn, Dohsik; Kim, Su Hwan; Do, Hyeon Nam; Kim, Byoungguk; Choi, Young Sill; Kim, Dong-Hyun; Oh, Eun-Jee; Oh, Kyungwon; Kwon, Donghyok; Kwon, Jun-Wook; Kim, Sung Soon; Lee, June-Woo.
Afiliação
  • Kim AR; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
  • Minn D; Medical Director for Diagnostic Immunology, Seegene Medical Foundation, Seoul, Korea.
  • Kim SH; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
  • Do HN; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
  • Kim B; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
  • Choi YS; Division of Pathogen Resource Management, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
  • Kim DH; Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, Korea.
  • Oh EJ; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Oh K; Division of Public Health Emergency Responses Research, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kwon D; Division of Public Health Emergency Responses Research, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kwon JW; National Institute of Health (NIH), Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim SS; Center for Vaccine Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee JW; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, Cheongju, Korea.
Epidemiol Health ; 44: e2022028, 2022.
Article em En | MEDLINE | ID: mdl-35209706
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article